Literature DB >> 3176900

Herpes-simplex-related antigen in human demyelinative disease and encephalitis.

J R Martin1, R K Holt, H D Webster.   

Abstract

Using immunohistochemical methods optimized to detect herpes simplex virus type 2 (HSV-2) antigen, paraffin sections from human central nervous system tissues from 31 cases pathologically diagnosed as multiple sclerosis (MS), 34 cases of other neurological diseases, 4 adult cases of HSV encephalitis, and mouse brains infected with various HSV strains were examined. Two distinct patterns of immunoreactivity with HSV antisera were seen. In typical acute human and experimental encephalitis, antigen was readily detected using high dilutions of antisera to both HSV types -1 and -2, and was found nonselectively in both neurons and glia. Lesions were destructive, with necrosis of all neural cell types, and inflammation was a mixture of polymorphonuclear and mononuclear cells. By contrast, immunoreactivity in lesions in each of three MS cases and in one case of brain stem encephalitis was found only with HSV-2 antisera, and relatively high antiserum concentrations were required to detect it. Reactivity appeared to be largely restricted to glial cell nuclei within and near lesions that were selectively demyelinated. Only mononuclear inflammation was present. These experiments suggest that HSV-related antigen may be found in a broader spectrum of human CNS lesions than has previously been recognized, and that HSV or a related agent may be associated with a selective infection of glial cells and with CNS demyelination.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3176900     DOI: 10.1007/bf00686969

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  36 in total

1.  Herpes simplex virus infection of in vitro cultured neuronal cells (mouse neuroblastoma C 1300 cells).

Authors:  A Vahlne; E Lycke
Journal:  J Gen Virol       Date:  1978-05       Impact factor: 3.891

2.  Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction.

Authors:  R Adler; J C Glorioso; M Levine
Journal:  J Gen Virol       Date:  1978-04       Impact factor: 3.891

3.  Herpesvirus hominis antibody in multiple sclerosis and amyotrophic lateral sclerosis.

Authors:  L W Catalano
Journal:  Neurology       Date:  1972-05       Impact factor: 9.910

4.  Herpesvirus infections of the human central nervous system.

Authors:  L C Olson; E L Buescher; M S Artenstein; P D Parkman
Journal:  N Engl J Med       Date:  1967-12-14       Impact factor: 91.245

5.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

6.  [Herpetic brainstem encephalitis--a case report].

Authors:  T Kitaguchi; S Suzuki; Y Itoyama; I Goto; Y Kuroiwa
Journal:  Rinsho Shinkeigaku       Date:  1985-02

7.  Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus.

Authors:  N Balachandran; D E Oba; L M Hutt-Fletcher
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

8.  Mitogen responsiveness and suppressor cell function in multiple sclerosis. Influence of age and disease activity.

Authors:  J P Antel; M Weinrich; B G Arnason
Journal:  Neurology       Date:  1978-10       Impact factor: 9.910

9.  Herpes simplex virus types 1 and 2 and multiple sclerosis.

Authors:  J R Martin
Journal:  Lancet       Date:  1981-10-10       Impact factor: 79.321

10.  Herpes simplex type 1 DNA in human brain tissue.

Authors:  N W Fraser; W C Lawrence; Z Wroblewska; D H Gilden; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  8 in total

1.  Negative association of Epstein-Barr virus or herpes simplex virus-1 with tumefactive central nervous system inflammatory demyelinating disease.

Authors:  Takao Kiriyama; Hiroshi Kataoka; Takahiko Kasai; Akitaka Nonomura; Satoshi Ueno
Journal:  J Neurovirol       Date:  2010-11-11       Impact factor: 2.643

2.  Atypical manifestations and poor outcome of herpes simplex encephalitis in the immunocompromised.

Authors:  Ik L Tan; Justin C McArthur; Arun Venkatesan; Avindra Nath
Journal:  Neurology       Date:  2012-11-07       Impact factor: 9.910

Review 3.  Multiple sclerosis: a unique immunopathological syndrome of the central nervous system.

Authors:  S F Hunter; M Rodriguez
Journal:  Springer Semin Immunopathol       Date:  1995

4.  Acute ascending necrotizing myelitis in Okinawa caused by herpes simplex virus type 2.

Authors:  T Iwamasa; H Yoshitake; H Sakuda; Y Kamada; M Miyazato; Y Utsumi; A Nakamura
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

5.  Two cases of necrotizing myelopathy associated with malignancy caused by herpes simplex virus type 2.

Authors:  T Iwamasa; Y Utsumi; H Sakuda; H Yoshitake; T Kakazu; R Kubota; M Nakagawa
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

6.  Detection of infectious agents in brain of patients with acute hemorrhagic leukoencephalitis.

Authors:  Shu F An; Michael Groves; Lillian Martinian; Lu T Kuo; Francesco Scaravilli
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 3.739

7.  The effect of mouse strain on herpes simplex virus type 1 (HSV-1) infection of the central nervous system (CNS).

Authors:  Lorne F Kastrukoff; Allen S Lau; Eva E Thomas
Journal:  Herpesviridae       Date:  2012-03-26

Review 8.  Brainstem encephalitis: an unusual presentation of herpes simplex virus infection.

Authors:  Daniel Livorsi; Eric Anderson; Sakib Qureshi; Marion Howard; Yun F Wang; Carlos Franco-Paredes
Journal:  J Neurol       Date:  2010-05-22       Impact factor: 6.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.